Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in Germany
2005 ECCO 13: The European Cancer Conference, October 30 - November 3, 2005, Paris, France
Aballea, S. | Frick, M. | Diel, R. | Rosenfeld, S. | Huppertz, R. | Sievert, M. | Jourdan, S. | Drummond, M. | Weinstein, M. | Reidchardt, P. |
Volume: ,
Issue: ,
Pages: ,
cost-effectiveness analysis, analysis, colon cancer, Germany,